Registry and biosample collection for cancer patients undergoing radiotherapy
Registry and Biosample Repository
This study is collecting blood, urine, and tumor samples from cancer patients receiving radiotherapy to see how the treatment affects them and to help improve future care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 8000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Abramson Cancer Center at Penn Medicine Academic / other |
| Locations | 4 sites (Moorestown, New Jersey and 3 other locations) |
| Trial ID | NCT01577251 on ClinicalTrials.gov |
What this trial studies
This study aims to create a comprehensive registry and biosample repository that includes blood, urine, and tumor specimens from patients diagnosed with cancer or benign tumors who are receiving radiotherapy. By collecting these samples, researchers hope to better understand the effects of radiotherapy and improve treatment outcomes. The study is observational, meaning it will gather data without intervening in the treatment process. Participants will be recruited from various cancer centers in New Jersey and Pennsylvania.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 18 and older who have a diagnosis of cancer or a benign tumor and are undergoing radiotherapy.
Not a fit: Patients who are not undergoing radiotherapy or are under 18 years old may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of radiotherapy effects and lead to improved treatment strategies for cancer patients.
How similar studies have performed: Other studies have successfully established similar registries and biosample repositories, indicating that this approach is both viable and beneficial for advancing cancer research.
Eligibility criteria
Show full inclusion / exclusion criteria
* Anyone age 18 and above with a cancer and/or benign tumor diagnosis undergoing radiotherapy * Able to sign consent
Where this trial is running
Moorestown, New Jersey and 3 other locations
- Virtua Samson Cancer Center — Moorestown, New Jersey, United States (Not_yet_recruiting)
- Virtua Health & Wellness Center — Voorhees Township, New Jersey, United States (Recruiting)
- Lancaster General Hospital — Lancaster, Pennsylvania, United States (Recruiting)
- University of Pennsylvania — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Jay Dorsey, MD, PhD — University of Pennsylvania
- Study coordinator: Project Manager
- Email: radonccru@pennmedicine.upenn.edu
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.